Document is current
Any future updates will be listed below
-
Authors
Lüker, Jakob https://orcid.org/0000-0003-4667-2200
Strik, Marc
Andrade, Jason G.
Raymond-Paquin, Alexandre
Elrefai, Mohamed Hassan
Roberts, Paul R.
Pérez, Óscar Cano
Kron, Jordana
Koneru, Jayanthi
Franqui-Rivera, Hilton
Sultan, Arian
Ernst, Angela
Schmitt, Jörn
Pott, Alexander
Veltmann, Christian
Srinivasan, Neil T
Collinson, Jason
van Stipdonk, Antonius M. W.
Linz, Dominik
Fluschnik, Nina
Tönnis, Tobias
Haeberlin, Andreas
Ploux, Sylvain
Steven, Daniel
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 15 November 2022
Accepted: 10 January 2023
First Online: 18 January 2023
Declarations
:
: This study received ethics committee approval
: All patients gave informed written consent prior to their medical procedures.
: Dr. Fluschik received grants from Biotronik and Medtronic not related to this work. Dr. Haeberlin has received travel fees/educational grants from Medtronic, Philips/Spectranetics and Biotronik without impact on his personal remuneration. He serves as a proctor for Medtronic. He is Co-founder and CEO of Act-Inno, a cardiovascular device testing company. Dr. Roberts has received Honoraria from Boston Scientific, Medtronic, and EBR systems Ltd. Dr. Elrefai has received research funding from Boston Scientific. Dr. Veltmann has received honoraria for lectures or consultant activity from Bayer, Biotronik, Medtronic, and Abbott. The remaining authors report no relevant conflict of interest in the context of this work.
